返回
M
Merck Sharp And Dohme
学者数5
论文数4
被引数0
关联论文 (4)
发表时间
Real-World Clinical Outcomes of Lenvatinib+Pembrolizumab for the Treatment of Patients With Non-Microsatellite Instability-High/Mismatch Repair Proficient Recurrent or Advanced Endometrial Cancer Following Prior Systemic Therapy in the United States美国真实世界临床结局:lenvatinib联合pembrolizumab治疗既往系统治疗后非微卫星不稳定性高/错配修复功能完整的复发性或晚期子宫内膜癌患者的效果

